Literature DB >> 3031313

Primary structure of poliovirus defective-interfering particle genomes and possible generation mechanisms of the particles.

S Kuge, I Saito, A Nomoto.   

Abstract

The genomes of defective-interfering (DI) particles derived from the Sabin strain of type 1 poliovirus (PV1(Sab] were characterized by nuclease S1 mapping using complementary DNA (cDNA) copies of PV1(Sab) genome as probes. The results demonstrated variety in the size and location of the deletions, which were compatible with our previous prediction. The results further indicated that the locations of the deletions were limited within the internal genome region encoding viral capsid proteins and that the deletion sites were clustered in certain areas on the genome. Sequence analysis of a number of cloned cDNAs to the DI genomes revealed that every DI genome retained the correct reading frame for viral protein synthesis. These results strongly suggested that one or all of the viral non-structural proteins might be cis-acting at least at a certain stage in viral replication. A computer search for secondary structures with regard to the deletion sites provided a possible common structure from which, supported by sequences existing on the plus or minus RNA strand of PV1(Sab), deletion regions looped out from the remaining sequences. Replicase might, therefore, skip these transiently formed loop structures with certain frequencies, resulting in the generation of DI genomes. This model could also be considered as a model for genetic recombination in these RNA genomes. Possible "supporting sequences" were also found for every rearranged site on the RNAs of influenza virus and sindbis virus. Thus, we propose a new copy-choice model, designated the "supporting sequence-loop model", for the generation of rearrangements occurring on single-stranded RNA genomes.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3031313     DOI: 10.1016/0022-2836(86)90270-6

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  62 in total

1.  Structure and function analysis of the poliovirus cis-acting replication element (CRE).

Authors:  Ian G Goodfellow; David Kerrigan; David J Evans
Journal:  RNA       Date:  2003-01       Impact factor: 4.942

2.  A poliovirus replicon containing the chloramphenicol acetyltransferase gene can be used to study the replication and encapsidation of poliovirus RNA.

Authors:  N Percy; W S Barclay; M Sullivan; J W Almond
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  The fitness of defective interfering murine coronavirus DI-a and its derivatives is decreased by nonsense and frameshift mutations.

Authors:  R J de Groot; R G van der Most; W J Spaan
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Nonreplicative homologous RNA recombination: promiscuous joining of RNA pieces?

Authors:  Anatoly P Gmyl; Sergey A Korshenko; Evegny V Belousov; Elena V Khitrina; Vadim I Agol
Journal:  RNA       Date:  2003-10       Impact factor: 4.942

5.  Evolution of poliovirus defective interfering particles expressing Gaussia luciferase.

Authors:  Yutong Song; Aniko V Paul; Eckard Wimmer
Journal:  J Virol       Date:  2011-12-07       Impact factor: 5.103

Review 6.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

7.  trans rescue of a mutant poliovirus RNA polymerase function.

Authors:  W A Charini; C C Burns; E Ehrenfeld; B L Semler
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

8.  Engineering of homologous recombination hotspots with AU-rich sequences in brome mosaic virus.

Authors:  P D Nagy; J J Bujarski
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

9.  RNA binding properties of poliovirus subviral particles.

Authors:  C I Nugent; K Kirkegaard
Journal:  J Virol       Date:  1995-01       Impact factor: 5.103

10.  A model for rearrangements in RNA genomes.

Authors:  E V Pilipenko; A P Gmyl; V I Agol
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.